Predictive biomarkers for anthacycline benefit in early breast cancer
More>>

Measuring the quality of care provided to patients with colorectal cancer
More>>

Innovations in assessment and management of breakthrough cancer pain
Challenges and successes
More>>
Funded by an educational grant from Meda Valeant Pharma
Canada Inc.

Search article archive       

We welcome your letters and suggestions for future articles.

Please address correspondence to Emily Andrews, Managing Editor, at andrews@parkpub.com

  Back to Top of Page

 

 

Reports from MASCC and ASCO

SUPPORTIVE CARE: symptom patterns in patients with advanced cancer

COLON CANCER: biochemical markers

BREAST CANCER: nab-paclitaxel in metastatic disease

RENAL CANCER: advanced disease

More>>

 

 
© Parkhurst Publishing 2004-2009 Privacy Statement
Legal Terms of Use
Site created by Spin Design (514) 995-4398